Agreed Risk, I was disappointed when I read the PR. I think everyone expected an announcement to the world of " the first blood test for AD" was going to hit the market by the end of the year, instead we got a confusing set of data that only researchers can understand.
Oh well, nothing new.
Still waiting patiently... AMBS
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links